Value Chain Assessment

Value chain transformation is one of the most noticeable activity identified in the pharmaceutical industry due to increasing global expansion & penetration of companies, dynamic regulatory policies, and pricing competition. The three major components of the pharmaceutical value chain are discovery, drug manufacturing, distribution, and dispensing to the patient. Since last decade pharmaceutical industry has observed various changes and significant challenges such as rise of generics has ignited the intensity of competition, complex & niche product portfolios, large drugstore chains imposing high standards for OTC products, and downward pressure on prices by healthcare providers and government bodies. In addition to this, the increasing crisis of counterfeit drugs has forced pharmaceutical companies to transform robust and efficiently traceable value chains. The outsourcing model is most preferred model recently by all pharmaceutical companies operating globally with their R&D partners, suppliers, logistics partner, and contract manufacturing organizations. Thus, Credence Research provides end to end assistance for our clients to enhance the performance of value chain and achieve swift, effective, and cost-efficient value chain.